Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2023-08-04 Delisting Announcement
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Delisting Announcement Classification · 95% confidence The document is a press release announcing a corporate action: the transfer of Mauna Kea Technologies' ordinary shares from the Euronext Paris regulated market to the Euronext Growth Paris multilateral trading facility, effective August 8, 2023. This action involves a change in listing venue, which is a significant capital structure/financing event, but more specifically, it is a formal announcement regarding the status of its listing and trading venue. While it mentions a shareholder meeting authorization, the core subject is the listing change. This type of announcement, detailing a change in listing status or a corporate action related to capital structure/financing, fits best under Capital/Financing Update (CAP). It is not a full 10-K, an ER, or a simple DIV notice. Since the document is an announcement detailing a change in the structure of its listing, CAP is the most appropriate fit over the general RNS fallback.
2023-08-04 English
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly information regarding the total number of voting rights and shares comprising the share capital' and explicitly references French regulatory articles (Commercial Code, AMF General Regulations). It provides a table detailing the number of shares and total voting rights as of a specific date (June 30, 2023). This type of regular disclosure concerning the total share capital and voting rights structure is a specific regulatory requirement, often related to major shareholding notifications or capital structure updates. While it touches upon share capital, the primary focus is the monthly disclosure of voting rights. This fits best under 'Major Shareholding Notification' (MRQ) as it reports on the current state of the capital structure relevant to ownership thresholds, or potentially 'Regulatory Filings' (RNS) if a more specific code isn't available. Given the specific nature of reporting total voting rights monthly, MRQ is the most appropriate fit among the provided options, as it relates directly to the composition of the share capital relevant for ownership reporting.
2023-08-03 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions composant le capital social" (Information relative to the total number of voting rights and shares comprising the share capital) and explicitly references Article L233-8-II of the French Commercial Code and Article 223-16 of the AMF General Regulation. It provides a table detailing the number of outstanding shares and total gross/net voting rights as of July 31, 2023. This type of mandatory periodic disclosure in France, focusing specifically on the total share capital and voting rights, is a standard regulatory filing. While it relates to capital structure, it is not a general financing update (CAP) or a share issue announcement (SHA). It is a specific regulatory disclosure regarding ownership structure and voting power, which fits best under the general regulatory filing category (RNS) or, more specifically, a notification related to share capital/voting rights, which is often captured by specific local codes not explicitly listed, making RNS the most appropriate general regulatory bucket, or potentially DVA if it were related to a vote result, but here it is a static count. Given the options, this is a mandatory regulatory disclosure about the capital structure, which is often grouped under general regulatory filings (RNS) when a more specific code like 'Share Issue/Capital Change' (SHA) doesn't perfectly capture the periodic nature of the voting rights disclosure. However, since it is a direct notification about the total number of shares and voting rights, it is a fundamental disclosure about the capital base. Since there is no specific code for 'Total Voting Rights Disclosure', RNS (Regulatory Filings) is the best fit as a mandatory regulatory announcement.
2023-08-03 French
Inside Information / Other news releases
Earnings Release Classification · 100% confidence The document is titled "Mauna Kea Technologies Reports Second Quarter and First Half 2023 Revenue" and contains detailed financial figures, revenue breakdowns by category and geography, and commentary on performance for Q2 and H1 2023. This structure is characteristic of an initial announcement of periodic financial results, which aligns with the definition of an Earnings Release (ER). Although it covers half-year results, the primary focus on the most recent quarter's revenue release places it firmly in the ER category, rather than the more comprehensive Interim/Quarterly Report (IR) or the Annual Report (10-K). It is not a transcript (CT), a presentation (IP), or a formal regulatory filing announcement (RPA/RNS) as it contains the results themselves, not just an announcement that results are forthcoming (though it does mention the next release date). Q2 2023
2023-07-20 English
Informations privilégiées / Autres communiqués
Earnings Release Classification · 100% confidence The document is titled "Mauna Kea Technologies annonce son chiffre d'affaires pour le 2ème trimestre et le 1er semestre 2023" (Mauna Kea Technologies announces its revenue for the 2nd quarter and the first half of 2023). It presents key financial highlights, detailed tables comparing Q2 2023 vs Q2 2022 and H1 2023 vs H1 2022 revenue figures, and management commentary on the results. This structure is characteristic of an initial announcement of periodic financial results, focusing on key figures rather than the comprehensive detail found in a full Quarterly Report (IR). Therefore, it aligns best with the Earnings Release (ER) definition. H1 2023
2023-07-20 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Monthly information regarding the total number of voting rights and shares comprising the share capital' and provides a table detailing the number of shares and voting rights as of June 30, 2023. This type of periodic disclosure, mandated by regulations like the AMF (French financial market authority), specifically concerns the capital structure and voting rights. Among the provided definitions, none perfectly match a 'Monthly Voting Rights Disclosure'. However, this information is a specific type of regulatory disclosure related to share capital and ownership structure. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is most closely related to changes in share capital or major shareholding notifications, but the content is a routine monthly update on the total count. Given the options, it is a specific regulatory filing that doesn't fit the primary categories like AGM, 10-K, or ER. It is a specific disclosure about the share base. Since it is a formal, periodic disclosure related to the company's structure and not a general announcement of a report (RPA) or a general miscellaneous filing (RNS), I must check if it fits better elsewhere. It is not a Director's Dealing (DIRS) or Major Shareholding Notification (MRQ) which focus on specific transactions or thresholds crossed by individuals/entities. Since it is a formal, periodic regulatory disclosure about the share base, and no better fit exists, it defaults to the general Regulatory Filings category (RNS) as the most appropriate fallback for specific, non-standard regulatory updates, although it is highly specific. Re-evaluating the options: It is not a Share Issue/Capital Change (SHA) as it's a report of the current state, not an announcement of a change being made. Given the highly specific nature of the disclosure (voting rights count), and the lack of a dedicated code, RNS (Regulatory Filings) is the best fit as a catch-all for mandatory, non-core financial disclosures.
2023-07-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.